Inotek Pharmaceuticals begin dosing in pivotal phase III study of trabodenoson Oct. 21, 2015 No Comments
Avalanche Biotechnologies reports 1-year follow up from phase I trial of rAAV.sFLT-1 Oct. 20, 2015 No Comments